Integris Cancer Institute is a clinical research site located in Oklahoma City, Oklahoma, United States 73142.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Integris Cancer Institute has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Follicular Lymphoma, Marginal Zone Lymphoma.
Sponsors: Incyte Corporation.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Integris Cancer Institute has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Integris Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Follicular Lymphoma, Marginal Zone Lymphoma.
Integris Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.